<div class="container">

<table style="width: 100%;"><tr>
<td>get.oc.obd2.kb</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Generate Operating Characteristics for OBD Finding Automaticallly</h2>

<h3>Description</h3>

<p>This function reports operating characteristics for optimal biological dose (OBD) finding automatically.
</p>


<h3>Usage</h3>

<pre><code class="language-R">get.oc.obd2.kb(
  target.toxicity,
  target.efficacy,
  ncohort = 10,
  cohortsize = 3,
  n.early = 100,
  startdose = 1,
  p.true,
  q.true,
  ntrial = 1000,
  seed = 6,
  p1 = 0.15,
  p2 = 0.4,
  q1 = 0.3,
  q2 = 0.6,
  cutoff.eli.toxicity = 0.95,
  cutoff.eli.efficacy = 0.3,
  w1.toxicity = 0.33,
  w2.toxicity = 1.09,
  indicator = target.toxicity
)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>target.toxicity</code></td>
<td>
<p>The target DLT rate.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>target.efficacy</code></td>
<td>
<p>The target efficacy rate.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>ncohort</code></td>
<td>
<p>The total number of cohorts.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>cohortsize</code></td>
<td>
<p>The number of patients in the cohort.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n.early</code></td>
<td>
<p>The early stopping parameter. If the number of patients treated at
the current dose reaches <code>n.early</code>, then we stop the trial
and select the optimal biological dose (OBD) based on the observed data. The default value is 100.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>startdose</code></td>
<td>
<p>The starting dose level.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p.true</code></td>
<td>
<p>A vector containing the true toxicity probabilities of the
investigational dose levels.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>q.true</code></td>
<td>
<p>A vector containing the true efficacy  probabilities of the
investigational dose levels.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>ntrial</code></td>
<td>
<p>The total number of trials to be simulated.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>seed</code></td>
<td>
<p>The random seed for simulation.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p1</code></td>
<td>
<p>The cutoff lower limit for safety utility function 1, described in the Details section.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p2</code></td>
<td>
<p>The cutoff upper limit for safety utility function 1, described in the Details section.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>q1</code></td>
<td>
<p>The cutoff lower limit for efficacy utility function 1, described in the Details section.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>q2</code></td>
<td>
<p>The cutoff upper limit for efficacy utility function 1, described in the Details section.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>cutoff.eli.toxicity</code></td>
<td>
<p>The cutoff to eliminate a dose with unacceptable high toxicity for safety.
The recommended value is 0.95.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>cutoff.eli.efficacy</code></td>
<td>
<p>The cutoff for the futility rule, the acceptable lowest efficacy.
The recommended value is 0.30.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>w1.toxicity</code></td>
<td>
<p>The weight for toxicity utility function 2 and 3, described in the Details section.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>w2.toxicity</code></td>
<td>
<p>The weight for toxicity utility function 3, described in the Details section.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>indicator</code></td>
<td>
<p>The indicator cutoff for utility function 3, described in the Details section.</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>A large number of  trials are simulated to characterize the operating characteristics of the Keyboard design under the prespecified true toxicity probabilities and true efficacy probabilities of the investigational doses.  The dose assignment follows the rules described in the function <code>get.decision.obd.kb()</code>.
</p>
<p>The following stopping rules are built in the Keyboard design:
</p>

<ol>
<li>
<p> Stop the trial if the lowest dose is eliminated from the trial due to high unacceptable toxicity.
</p>
</li>
<li>
<p> Stop the trial if the number of patients treated at current dose is larger than or equal to <code>n.earlystop</code>.
</p>
</li>
</ol>
<h3>Value</h3>

<p><code>get.oc.obd2.kb()</code> returns the operating characteristics of the Keyboard design as a list, including:<br></p>

<ol>
<li>
<p> the selection percentage at each dose level using utility function 1 (<code>$selpercent1</code>), <br></p>
</li>
<li>
<p> the selection percentage at each dose level using utility function 2 (<code>$selpercent2</code>), <br></p>
</li>
<li>
<p> the selection percentage at each dose level using utility function 3 (<code>$selpercent3</code>), <br></p>
</li>
<li>
<p> the number of patients treated at each dose level (<code>$npatients</code>), <br></p>
</li>
<li>
<p> the number of dose-limiting toxicities (DLTs) observed at each dose level (<code>$ntox</code>), <br></p>
</li>
<li>
<p> the number of responses observed at each dose level (<code>$neff</code>), <br></p>
</li>
<li>
<p> the average number of DLTs (<code>$totaltox</code>), <br></p>
</li>
<li>
<p> the average number of responses (<code>$totaleff</code>), <br></p>
</li>
<li>
<p> the average number of patients (<code>$totaln</code>), <br></p>
</li>
<li>
<p> the percentage of early stopping without selecting the OBD using utility function 1 (<code>$percentstop1</code>), <br></p>
</li>
<li>
<p> the percentage of early stopping without selecting the OBD using utility function 2 (<code>$percentstop2</code>), <br></p>
</li>
<li>
<p> the percentage of early stopping without selecting the OBD using utility function 3 (<code>$percentstop3</code>), <br></p>
</li>
<li>
<p> data.frame (<code>$simu.setup</code>) containing simulation parameters, such as target, p.true, etc.
</p>
</li>
</ol>
<h3>Author(s)</h3>

<p>Xiaomeng Yuan, Chen Li, Hongying Sun, Li Tang and Haitao Pan
</p>


<h3>References</h3>

<p>Li DH, Whitmore JB, Guo W, Ji Y.  Toxicity and efficacy probability interval design for phase I adoptive cell therapy dose-finding clinical trials.
<em>Clinical Cancer Research</em>. 2017; 23:13-20.
https://clincancerres.aacrjournals.org/content/23/1/13.long
</p>
<p>Liu S, Johnson VE.  A robust Bayesian dose-finding design for phase I/II clinical trials. <em>Biostatistics</em>. 2016; 17(2):249-63.
https://academic.oup.com/biostatistics/article/17/2/249/1744018
</p>
<p>Zhou Y, Lee JJ, Yuan Y.  A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies. <em>Statistics in Medicine</em>. 2019; 38:S5299-5316.
https://onlinelibrary.wiley.com/doi/epdf/10.1002/sim.8361
</p>


<h3>See Also</h3>

<p>Other single-agent phase I/II functions: 
<code>get.decision.obd.kb()</code>,
<code>get.decision.obd2.kb()</code>,
<code>get.oc.obd.kb()</code>,
<code>select.obd.kb()</code>
</p>


<h3>Examples</h3>

<pre><code class="language-R">
target.toxicity &lt;- 0.30
target.efficacy &lt;- 0.40
p.true &lt;-c(0.08,0.30,0.60,0.80)
q.true &lt;- c(0.25,0.40,0.25,0.50)
oc.obd2.kb &lt;- get.oc.obd2.kb(target.toxicity=target.toxicity,
              target.efficacy= target.efficacy, ncohort=20,
              cohortsize= 3,  p.true= p.true, q.true= q.true)
oc.obd2.kb
summary_kb(oc.obd2.kb)
plot_kb(oc.obd2.kb)
plot_kb(oc.obd2.kb$selpercent1)
plot_kb(oc.obd2.kb$selpercent2)
plot_kb(oc.obd2.kb$selpercent3)
plot_kb(oc.obd2.kb$npatients)
plot_kb(oc.obd2.kb$ntox)
plot_kb(oc.obd2.kb$neff)


</code></pre>


</div>